litlas
Log inCreate account

Stephan A. Grupp

Active 1993–2025

192
Papers
60,305
Citations
105
h-index
189
i10-index

Citations

Citations per year for Stephan A. Grupp1990: 4 citations1991: 4 citations1992: 1 citations1994: 2 citations1995: 3 citations1996: 5 citations1997: 6 citations1998: 1 citations1999: 2 citations2000: 2 citations2001: 7 citations2002: 4 citations2003: 8 citations2004: 10 citations2005: 22 citations2006: 18 citations2007: 30 citations2008: 27 citations2009: 37 citations2010: 46 citations2011: 79 citations2012: 123 citations2013: 264 citations2014: 303 citations2015: 598 citations2016: 723 citations2017: 907 citations2018: 1,148 citations2019: 2,793 citations2020: 3,835 citations2021: 3,900 citations2022: 3,252 citations2023: 2,663 citations2024: 3,866 citations2025: 2,289 citations2026: 87 citations1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,912 citing papers, 32.1% of this breakdownChina: 2,520 citing papers, 11.7% of this breakdownGermany: 1,435 citing papers, 6.7% of this breakdownUnited Kingdom: 1,080 citing papers, 5% of this breakdownItaly: 918 citing papers, 4.3% of this breakdownFrance: 831 citing papers, 3.8% of this breakdownSpain: 659 citing papers, 3.1% of this breakdownCanada: 623 citing papers, 2.9% of this breakdownNetherlands: 540 citing papers, 2.5% of this breakdownSwitzerland: 512 citing papers, 2.4% of this breakdownAustralia: 493 citing papers, 2.3% of this breakdownJapan: 441 citing papers, 2% of this breakdown
0%32.1%Other 21.2%

Institutions

Fields

  • Medicine77.8%
  • Biochemistry, Genetics and Molecular Biology12.6%
  • Immunology and Microbiology7.3%
  • Engineering0.9%
  • Neuroscience0.3%
  • Materials Science0.3%
  • Other0.8%

Topics

  • CAR-T cell therapy research20.5%
  • Immune Cell Function and Interaction6.1%
  • Virus-based gene therapy research5.8%
  • Immunotherapy and Immune Responses4.4%
  • Nanowire Synthesis and Applications3.4%
  • Cancer Immunotherapy and Biomarkers3%
  • Other56.8%

Coauthors

All papers

Open in search
  1. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    Authors: Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R. Verneris, Heather E. Stefanski, Gary D. Myers, Muna Qayed, Barbara De Moerloose, Hidefumi Hiramatsu, Krysta Schlis, Kara L. Davis, Paul L. Martin, Eneida R. Nemecek, Gregory A. Yanik, Christina Peters, André Baruchel, Nicolas Boissel, Françoise Méchinaud, Adriana Balduzzi, Joerg Krueger, Carl H. June, Bruce L. Levine, Patricia A. Wood, Tetiana Taran, Mimi Leung, Karen T. Mueller, Yiyun Zhang, Kapildeb Sen, David Lebwohl, Michael A. Pulsipher, Stephan A. Grupp - New England Journal of Medicine 2018 cited by 5,641

  2. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

    Authors: Daniel W. Lee, Bianca Santomasso, Frederick L. Locke, Armin Ghobadi, Cameron J. Turtle, Jennifer N. Brudno, Marcela V. Maus, Jae H. Park, Elena Mead, Steven Z. Pavletic, William Y. Go, Lamis Eldjerou, Rebecca Gardner, Noelle V. Frey, Kevin J. Curran, Karl S. Peggs, Marcelo C. Pasquini, John F. DiPersio, Marcel R.M. van den Brink, Krishna V. Komanduri, Stephan A. Grupp, Sattva S. Neelapu - Biology of Blood and Marrow Transplantation 2018 cited by 3,445

  3. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

    Authors: Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, Richard Aplenc, David M. Barrett, Nancy Bunin, Anne Chew, Vanessa Gonzalez, Zhaohui Zheng, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Susan R. Rheingold, Angela Shen, David T. Teachey, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp - New England Journal of Medicine 2014 cited by 5,408

  4. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

    Authors: Haydar Frangoul, David Altshuler, Maria Domenica Cappellini, Yi-Shan Chen, Jennifer Domm, Brenda K. Eustace, Juergen Foell, Josu de la Fuente, Stephan A. Grupp, Rupert Handgretinger, Tony W. Ho, Antonis Kattamis, Andrew Kernytsky, Julie Lekstrom-Himes, Amanda M. Li, Franco Locatelli, Markus Y. Mapara, Mariane de Montalembert, Damiano Rondelli, Akshay Sharma, Sujit Sheth, Sandeep Soni, Martin H. Steinberg, Donna A. Wall, Angela Yen, Selim Corbacioglu - New England Journal of Medicine 2020 cited by 1,856

  5. ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

    Authors: Stéphane Depil, Philippe Duchâteau, Stephan A. Grupp, G J Mufti, Laurent Poirot - Nature Reviews Drug Discovery 2020 cited by 1,183

  6. Current concepts in the diagnosis and management of cytokine release syndrome

    Authors: Daniel W. Lee, Rebecca Gardner, David Porter, Chrystal U. Louis, Nabil Ahmed, Michael C. Jensen, Stephan A. Grupp, Crystal L. Mackall - Blood 2014 cited by 2,795

  7. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

    Authors: Stephan A. Grupp, Michael Kalos, David M. Barrett, Richard Aplenc, David L. Porter, Susan R. Rheingold, David T. Teachey, Anne Chew, Bernd Hauck, J. Fraser Wright, Michael C. Milone, Bruce L. Levine, Carl H. June - New England Journal of Medicine 2013 cited by 3,491

  8. In vivo hematopoietic stem cell modification by mRNA delivery

    Authors: Laura Breda, Tyler E. Papp, Michael Triebwasser, Amir Yadegari, Megan T. Fedorky, Naoto Tanaka, Osheiza Abdulmalik, Giulia Pavani, Yongping Wang, Stephan A. Grupp, Stella T. Chou, Houping Ni, Barbara L. Mui, Ying K. Tam, Drew Weissman, Stefano Rivella, Hamideh Parhiz - Science 2023 cited by 304

  9. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

    Authors: David Porter, Wei‐Ting Hwang, Noelle V. Frey, Simon F. Lacey, Pamela A. Shaw, Alison W. Loren, Adam Bagg, Katherine T. Marcucci, Angela Shen, Vanessa Gonzalez, David E Ambrose, Stephan A. Grupp, Anne Chew, Zhaohui Zheng, Michael C. Milone, Bruce L. Levine, J. Joseph Melenhorst, Carl H. June - Science Translational Medicine 2015 cited by 1,727

  10. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

    Authors: Michael Kalos, Bruce L. Levine, David L. Porter, Sharyn I. Katz, Stephan A. Grupp, Adam Bagg, Carl H. June - Science Translational Medicine 2011 cited by 2,403

  11. Unanswered questions following reports of secondary malignancies after CAR-T cell therapy

    Authors: Bruce L. Levine, Marcelo C. Pasquini, John E. Connolly, David L. Porter, Michael P. Gustafson, Jaap Jan Boelens, Edwin M. Horwitz, Stephan A. Grupp, Marcela V. Maus, Frederick L. Locke, Fabio Ciceri, Annalisa Ruggeri, John A. Snowden, Helen E. Heslop, Crystal L. Mackall, Carl H. June, Anna M. Sureda, Miguel‐Angel Perales - Nature Medicine 2024 cited by 196

  12. Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy

    Authors: Elena Sotillo, David M. Barrett, Kathryn L. Black, Asen Bagashev, Derek A. Oldridge, Glendon Wu, Robyn T. Sussman, Claudia Lanauze, Marco Ruella, Matthew R. Gazzara, Nicole M. Martínez, Colleen T. Harrington, Elaine Y. Chung, Jessica Perazzelli, Ted J. Hofmann, Shannon L. Maude, Pichai Raman, Alejandro Barrera, Saar Gill, Simon F. Lacey, Jan J. Melenhorst, David Allman, Elad Jacoby, Terry J. Fry, Crystal L. Mackall, Yoseph Barash, Kristen W. Lynch, John M. Maris, Stephan A. Grupp, Andrei Thomas‐Tikhonenko - Cancer Discovery 2015 cited by 1,254

  13. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

    Authors: David T. Teachey, Simon F. Lacey, Pamela A. Shaw, J. Joseph Melenhorst, Shannon L. Maude, Noelle V. Frey, Edward Pequignot, Vanessa Gonzalez, Fang Chen, Jeffrey Finklestein, David M. Barrett, Scott L. Weiss, Julie C. Fitzgerald, Robert A. Berg, Richard Aplenc, Colleen Callahan, Susan R. Rheingold, Zhaohui Zheng, Stefan Rose‐John, Jason C. White, Farzana Nazimuddin, Gerald Wertheim, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp - Cancer Discovery 2016 cited by 1,084

  14. Exagamglogene Autotemcel for Severe Sickle Cell Disease

    Authors: Haydar Frangoul, Franco Locatelli, Akshay Sharma, Monica Bhatia, Markus Y. Mapara, Lyndsay Molinari, Donna A. Wall, Robert I. Liem, Paul Telfer, Ami J. Shah, Marina Cavazzana, Selim Corbacioglu, Damiano Rondelli, Roland Meisel, Laurence Dedeken, Stephan Lobitz, Mariane de Montalembert, Martin H. Steinberg, Mark C. Walters, Michael J. Eckrich, Suzan Imren, Laura Bower, C Simard, Weiyu Zhou, Fengjuan Xuan, Phuong K. Morrow, William E. Hobbs, Stephan A. Grupp - New England Journal of Medicine 2024 cited by 380

  15. Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

    Authors: Theodore W. Laetsch, Shannon L. Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt, Peter Bader, André Baruchel, Michael Boyer, Barbara De Moerloose, Muna Qayed, Jochen Buechner, Michael A. Pulsipher, Gary Douglas Myers, Heather E. Stefanski, Paul L. Martin, Eneida R. Nemecek, Christina Peters, Gregory A. Yanik, Seong Lin Khaw, Kara L. Davis, Joerg Krueger, Adriana Balduzzi, Nicolas Boissel, Ranjan Tiwari, Darragh O’Donovan, Stephan A. Grupp - Journal of Clinical Oncology 2022 cited by 357

  16. Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

    Authors: Marco Ruella, Jun Xu, David M. Barrett, Joseph A. Fraietta, Tyler J. Reich, David E Ambrose, Michael Klichinsky, Olga Shestova, Prachi Patel, Irina Kulikovskaya, Farzana Nazimuddin, Vijay Bhoj, Elena J. Orlando, Terry J. Fry, Hans Bitter, Shannon L. Maude, Bruce L. Levine, Christopher L. Nobles, Frederic D. Bushman, Regina M. Young, John Scholler, Saar Gill, Carl H. June, Stephan A. Grupp, Simon F. Lacey, J. Joseph Melenhorst - Nature Medicine 2018 cited by 645

  17. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Authors: Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak, Wendy B. London, Susan G. Kreissman, Helen X. Chen, Malcolm A. Smith, Barry Anderson, Judith G. Villablanca, Katherine K. Matthay, Hiro Shimada, Stephan A. Grupp, Robert C. Seeger, C. Patrick Reynolds, Allen Buxton, Ralph A. Reisfeld, S. D. Gillies, Susan L. Cohn, John M. Maris, Paul M. Sondel - New England Journal of Medicine 2010 cited by 1,809

  18. FOXO1 is a master regulator of memory programming in CAR T cells

    Authors: Alexander Doan, Katherine P. Mueller, Andy Y. Chen, Geoffrey T. Rouin, Yingshi Chen, Bence Dániel, John Lattin, Martina Markovska, Brett Mozarsky, Jose Arias-Umana, Robert Hapke, In-Young Jung, Alice Wang, Peng Xu, Dorota D. Klysz, Gabrielle Zuern, Malek Bashti, Patrick J. Quinn, Zhuang Miao, Katalin Sándor, Wenxi Zhang, Gregory M. Chen, Faith Ryu, Meghan Logun, Junior Hall, Kai Tan, Stephan A. Grupp, Susan McClory, Caleb A. Lareau, Joseph A. Fraietta, Elena Sotillo, Ansuman T. Satpathy, Crystal L. Mackall, Evan W. Weber - Nature 2024 cited by 190

  19. Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

    Authors: Elena J. Orlando, Xia Han, Catherine Tribouley, Patricia A. Wood, Rebecca Leary, Markus Riester, John E. Levine, Muna Qayed, Stephan A. Grupp, Michael Boyer, Barbara De Moerloose, Eneida R. Nemecek, Henrique Bittencourt, Hidefumi Hiramatsu, Jochen Buechner, Stella M. Davies, Michael R. Verneris, Kevin T. Nguyen, Jennifer L. Brogdon, Hans Bitter, Michael Morrissey, Piotr Pierog, Serafino Pantano, Jeffrey A. Engelman, Wendy Winckler - Nature Medicine 2018 cited by 567

  20. Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo

    Authors: Michael C. Milone, Jonathan D. Fish, Carmine Carpenito, Richard G. Carroll, Gwendolyn K. Binder, David T. Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers, Dario Campana, James L. Riley, Stephan A. Grupp, Carl H. June - Molecular Therapy 2009 cited by 1,189

  21. Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy

    Authors: Gregory M. Chen, Changya Chen, Rajat K. Das, Peng Gao, Chia‐Hui Chen, Shovik Bandyopadhyay, Yangyang Ding, Yasin Uzun, Wenbao Yu, Qin Zhu, Regina M. Myers, Stephan A. Grupp, David M. Barrett, Kai Tan - Cancer Discovery 2021 cited by 205

  22. Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL

    Authors: Zhiliang Bai, Steven Woodhouse, Ziran Zhao, Rahul Singh Arya, Kiya W. Govek, Dongjoo Kim, Stefan Lundh, Alev Baysoy, Hongxing Sun, Yanxiang Deng, Yang Xiao, David M. Barrett, Regina M. Myers, Stephan A. Grupp, Carl H. June, Rong Fan, Pablo G. Cámara, J. Joseph Melenhorst - Science Advances 2022 cited by 161

  23. Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

    Authors: Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran, Theodore W. Laetsch, Frederick L. Locke, Rayne H. Rouce, Michael A. Pulsipher, Christine L. Phillips, Amy K. Keating, Matthew J. Frigault, Dana Salzberg, Samantha Jaglowski, Joshua Sasine, Joseph Rosenthal, Monalisa Ghosh, Daniel J. Landsburg, Steven Margossian, Paul L. Martin, Manali Kamdar, Peiman Hematti, Sarah Nikiforow, Cameron J. Turtle, Miguel‐Angel Perales, Patricia Steinert, Mary M. Horowitz, Amy Moskop, Lida Pacaud, Lan Yi, Raghav Chawla, Eric Bleickardt, Stephan A. Grupp - Blood Advances 2020 cited by 434

  24. Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells

    Authors: Saba Ghassemi, Selene Nuñez-Cruz, Roddy S. O’Connor, Joseph A. Fraietta, Prachi Patel, John Scholler, David M. Barrett, Stefan Lundh, Megan M. Davis, Felipe Bedoya, Changfeng Zhang, John Leferovich, Simon F. Lacey, Bruce L. Levine, Stephan A. Grupp, Carl H. June, J. Joseph Melenhorst, Michael C. Milone - Cancer Immunology Research 2018 cited by 302